References
E. Gregoric, J.A. Gregoric, F. Guarneri, S. Benvenga, Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine 39, 41–47 (2011)
B.Z. Dolimbek, K.R. Aoki, L.E. Steward, J. Jankovic, M.Z. Atassi, Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol. Immunol. 44, 1029–1041 (2007)
M.Z. Atassi, B.Z. Dolimbek, J. Jankovic, L.E. Steward, K.R. Aoki, Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies, Immunobiology. (2011). doi:10.1016/j.imbio.2010.12.009
Center for Drug Evaluation and Research, Summary review for regulatory action. Application Number 125274. (2009), http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/125274s000_SumR.pdf. Accessed 24 Mar 2009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atassi, M.Z., Deitiker, P.R. Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons?. Endocrine 40, 140–141 (2011). https://doi.org/10.1007/s12020-011-9481-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9481-2